Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | INCB161734 |
Trade Name | |
Synonyms | INCB-161734|INCB 161734 |
Drug Descriptions |
INCB161734 selectively inhibits KRAS G12D, potentially resulting in decreased cell proliferation and tumor growth (Cancer Res (2024) 84 (6_Supplement): 5900). |
DrugClasses | KRAS G12D Inhibitor 16 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetuximab + INCB161734 + Retifanlimab | Cetuximab INCB161734 Retifanlimab | 0 | 1 |
INCB161734 | INCB161734 | 0 | 1 |